×
Choose Speciality

EXPLORE!

LOGIN

By signing up or signing in to eMediNexus, you consent to eMediNexus collecting and using your personal data in accordance with our Privacy Policy. I consent to receive medical updates and communications from eMediNexus, it's parent company IJCP and its industry partners.

Empagliflozin in patients with Chronic Kidney Disease (Phase III EMPA-KIDNEY trial)

  734 Views

eMediNexus    01 December 2022

Reference: EMPA-KIDNEY Collaborative Group et al. "Empagliflozin in Patients with Chronic Kidney Disease." The New England journal of medicine, 10.1056/NEJMoa2204233. November 04, 2022.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.